Related Experiment Video
Updated: Feb 7, 2026

A Neuroscientific Approach to the Examination of Concussions in Student-Athletes
Published on: December 8, 2014
A Bayesian Approach for the Use of Athlete Performance Data Within Anti-doping
Silvia Montagna1, James Hopker2
1ESOMAS Department, University of Torino, Torino, Italy.
Abstract:
The World Anti-doping Agency currently collates the results of all doping tests for athletes involved in elite sporting competition with the aim of improving the fight against doping. Existing anti-doping strategies involve either the direct detection of use of banned substances, or abnormal variation in metabolites or biological markers related to their use. As the aim of any doping regime is to enhance athlete competitive performance, it is interesting to consider whether performance data could be used within the fight against doping. In this regard, the identification of unexpected increases in athlete performance could be used as a trigger for their closer scrutiny via a targeted anti-doping testing programme. This study proposes a Bayesian framework for the development of an "athlete performance passport" and documents some initial findings and limitations of such an approach. The Bayesian model was retrospectively applied to the competitive results of 1,115 shot put athletes from 1975 to 2016 in order establish the interindividual variability of intraindividual performance in order to create individualized career performance trajectories for a large number of presumed clean athletes. Data from athletes convicted for doping violations (3.69% of the sample) was used to assess the predictive performance of the Bayesian framework with a probit model. Results demonstrate the ability to detect performance differences (~1 m) between doped and presumed clean athletes, and achieves good predictive performance of doping status (i.e., doped vs. non-doped) with a high area under the curve (AUC = 0.97). However, the model prediction of doping status was driven by the correct classification of presume non-doped athletes, misclassifying doped athletes as non-doped. This lack of sensitivity is likely due to the need to accommodate additional longitudinal covariates (e.g., aging and seasonality effects) potentially affecting performance into the framework. Further research is needed in order to increase the framework structure and improve its accuracy and sensitivity.
Related Concept Videos
Performing a Simple Data Analysis using MS-Excel Function
SUM: This function calculates the total sum of a range of values. It's the foundation for aggregating data, essential for determining overall trends and totals in datasets.
AVERAGE: It computes the mean value of a given set of numbers, providing a quick insight into the central...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

